|
1
|
Vlahos I: Dilemmas in lung cancer staging.
Radiol Clin North Am. 56:419–435. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang Y, Jiang M, Du C, Yu Y, Liu Y, Li M
and Luo F: Utilization of lung cancer cell lines for the study of
lung cancer stem cells. Oncol Lett. 15:6791–6798. 2018.PubMed/NCBI
|
|
3
|
de Sousa VML and Carvalho L: Heterogeneity
in lung cancer. Pathobiology. 85:96–107. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharma A and Shepard JO: Lung cancer
biopsies. Radiol Clin North Am. 56:377–390. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shroff GS, Viswanathan C, Carter BW,
Benveniste MF, Truong MT and Sabloff BS: Staging lung cancer:
Metastasis. Radiol Clin North Am. 56:411–418. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brand T and Haithcock B: Lung cancer and
lung transplantation. Thorac Surg Clin. 28:15–18. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hayashi Y, Sawa Y, Fukuyama N, Nakazawa H
and Matsuda H: Preoperative glutamine administration induces
heat-shock protein 70 expression and attenuates cardiopulmonary
bypass-induced inflammatory response by regulating nitric oxide
synthase activity. Circulation. 106:2601–2607. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fahrner R, Trochsler M, Corazza N,
Graubardt N, Keogh A, Candinas D, Brunner T, Stroka D and Beldi G:
Tumor necrosis factor-related apoptosis-inducing ligand on NK cells
protects from hepatic ischemia-reperfusion injury. Transplantation.
97:1102–1109. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Souba WW, Klimberg VS, Plumley DA, Salloum
RM, Flynn TC, Bland KI and Copeland EM III: The role of glutamine
in maintaining a healthy gut and supporting the metabolic response
to injury and infection. J Surg Res. 48:383–391. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zou XP, Chen M, Wei W, Cao J, Chen L and
Tian M: Effects of enteral immunonutrition on the maintenance of
gut barrier function and immune function in pigs with severe acute
pancreatitis. JPEN J Parenter Enteral Nutr. 34:554–566. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peng ZY, Hamiel CR, Banerjee A, Wischmeyer
PE, Friese RS and Wischmeyer P: Glutamine attenuation of cell death
and inducible nitric oxide synthase expression following
inflammatory cytokine-induced injury is dependent on heat shock
factor-1 expression. JPEN J Parenter Enteral Nutr. 30:400–406;
discussion 406-7. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Von Bültzingslöwen I, Adlerberth I, Wold
AE, Dahlén G and Jontell M: Oral and intestinal microflora in
5-fluorouracil treated rats, translocation to cervical and
mesenteric lymph nodes and effects of probiotic bacteria. Oral
Microbiol Immunol. 18:278–284. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singleton KD, Serkova N, Banerjee A, Meng
X, Gamboni-Robertson F and Wischmeyer PE: Glutamine attenuates
endotoxin-induced lung metabolic dysfunction: Potential role of
enhanced heat shock protein 70. Nutrition. 21:214–223. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Butler EB, Zhao Y, Muñoz-Pinedo C, Lu J
and Tan M: Stalling the engine of resistance: Targeting cancer
metabolism to overcome therapeutic resistance. Cancer Res.
73:2709–2717. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barquissau V, Beuzelin D, Pisani DF,
Beranger GE, Mairal A, Montagner A, Roussel B, Tavernier G, Marques
MA, Moro C, et al: White-to-brite conversion in human adipocytes
promotes metabolic reprogramming towards fatty acid anabolic and
catabolic pathways. Mol Metab. 5:352–365. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kou Y, Zheng WT and Zhang YR: Inhibition
of miR-23 protects myocardial function from ischemia-reperfusion
injury through restoration of glutamine metabolism. Eur Rev Med
Pharmacol Sci. 20:4286–4293. 2016.PubMed/NCBI
|
|
17
|
Tanaka K, Sasayama T, Irino Y, Takata K,
Nagashima H, Satoh N, Kyotani K, Mizowaki T, Imahori T, Ejima Y, et
al: Compensatory glutamine metabolism promotes glioblastoma
resistance to mTOR inhibitor treatment. J Clin Invest.
125:1591–1602. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jacque N, Ronchetti AM, Larrue C, Meunier
G, Birsen R, Willems L, Saland E, Decroocq J, Maciel TT, Lambert M,
et al: Targeting glutaminolysis has antileukemic activity in acute
myeloid leukemia and synergizes with BCL-2 inhibition. Blood.
126:1346–1356. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McRae MP: Therapeutic benefits of
glutamine: An umbrella review of meta-analyses. Biomed Rep.
6:576–584. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuen CA, Asuthkar S, Guda MR, Tsung AJ and
Velpula KK: Cancer stem cell molecular reprogramming of the Warburg
effect in glioblastomas: A new target gleaned from an old concept.
CNS Oncol. 5:101–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pusapati RV, Daemen A, Wilson C, Sandoval
W, Gao M, Haley B, Baudy AR, Hatzivassiliou G, Evangelista M and
Settleman J: MTORC1-dependent metabolic reprogramming underlies
escape from glycolysis addiction in cancer cells. Cancer Cell.
29:548–562. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Csibi A, Lee G, Yoon SO, Tong H, Ilter D,
Elia I, Fendt SM, Roberts TM and Blenis J: The mTORC1/S6K1 pathway
regulates glutamine metabolism through the eIF4B-dependent control
of c-Myc translation. Curr Biol. 24:2274–2280. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kamata S, Kishimoto T, Kobayashi S,
Miyazaki M and Ishikura H: Possible involvement of persistent
activity of the mammalian target of rapamycin pathway in the
cisplatin resistance of AFP-producing gastric cancer cells. Cancer
Biol Ther. 6:1036–1043. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gini B, Zanca C, Guo D, Matsutani T, Masui
K, Ikegami S, Yang H, Nathanson D, Villa GR, Shackelford D, et al:
The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially
block the growth of EGFRvIII-activated glioblastomas. Clin Cancer
Res. 19:5722–5732. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pochini L, Scalise M, Galluccio M and
Indiveri C: Membrane transporters for the special amino acid
glutamine: Structure/function relationships and relevance to human
health. Front Chem. 2:612014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu W, Le A, Hancock C, Lane AN, Dang CV,
Fan TW and Phang JM: Reprogramming of proline and glutamine
metabolism contributes to the proliferative and metabolic responses
regulated by oncogenic transcription factor c-MYC. Proc Natl Acad
Sci USA. 109:8983–8988. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cetinbas F, Yelken B and Gulbas Z: Role of
glutamine administration on cellular immunity after total
parenteral nutrition enriched with glutamine in patients with
systemic inflammatory response syndrome. J Crit Care.
25:661.e1–661.e6. 2010. View Article : Google Scholar
|
|
28
|
Mousavi SN, Samini F, Nematy M, Philippou
E, Safarian M, Tavallaiee S and Norouzy A: Hyperglycemia and
antibody titres against heat shock protein 27 in traumatic brain
injury patients on parenteral nutrition. Iran J Basic Med Sci.
17:119–122. 2014.PubMed/NCBI
|
|
29
|
Chen H, Chen D, Michiels J and De Smet S:
Dietary fiber affects intestinal mucosal barrier function by
regulating intestinal bacteria in weaning piglets. Commun Agric
Appl Biol Sci. 78:71–78. 2013.PubMed/NCBI
|
